Last reviewed · How we verify
NCT04408482
Does Pancreatic Stent Decrease the Risk of Pancreatitis After Pancreatic Sphincterotomy for Difficult Cannulation?
NA trial testing Biliary cannulation in Endoscopic Retrograde Cholangiopancreatography in 268 participants. Currently enrolling.
1 September 2028
Quick facts
| Lead sponsor | Helsinki University Central Hospital |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 268 |
| Start date | 1 August 2020 |
| Primary completion | 1 September 2028 |
| Estimated completion | 1 September 2028 |
| Sites | 1 location across Finland |
Drugs / interventions tested
- Biliary cannulation
Conditions studied
- Endoscopic Retrograde Cholangiopancreatography — all drugs for Endoscopic Retrograde Cholangiopancreatography →
Sponsor
Helsinki University Central Hospital
Who can join
Adults 18 to 100, any sex, with Endoscopic Retrograde Cholangiopancreatography. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of the study is to compare the risk of PEP after pancreatic sphincterotomy performed for difficult cannulation in a group of patients with and in a group of patients without placement of a prophylactic pancreatic stent. The definition of difficult cannulation is defined according to the literature.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT04408482
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Endoscopic Retrograde Cholangiopancreatography
Currently open trials in the same condition.
- NCT07440342 — TEAS for Sedation During ERCP: A Multicenter Trial · NA · recruiting
- NCT06716541 — Biodegradable Stents in Liver Transplant RecipIents for Treatment of Biliary Anastomotic Strictures · NA · recruiting
- NCT06776874 — Observational Study to Develop a Predictive Score for Adverse Events Post ERCP · recruiting
Other Helsinki University Central Hospital trials
Trials by the same sponsor.
- NCT07423637 — The Impact of Early Automated Insulin Delivery (AID) Therapy on Diabetes Control and Comorbidities, and Cost-effectivene · NA · not yet recruiting
- NCT07462559 — KF2025#1 Trial: Ketamine, Cannabidiol and Cobicistat Interaction Study · Phase 1 · not yet recruiting
- NCT07458984 — FMT Capsules for rCDI · Phase 3 · not yet recruiting
- NCT07001423 — ChOlecystectomy aFter successFul Endoscopic Common Bile Duct Stone Extraction in Elderly · NA · recruiting
- NCT07155629 — Neoadjuvant Treatment vs Upfront Surgery for Left-Sided Pancreatic Cancer · Phase 3 · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04408482 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Helsinki University Central Hospital
- Last refreshed: 3 March 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04408482.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing